Aegerion Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 91   

Articles published

AEGR 20.38
price chart
Why Aegerion Pharmaceuticals, Inc. Stock Collapsed in October
What: Shares of Aegerion Pharmaceuticals (NASDAQ: AEGR ) , a biopharmaceutical company focused on developing drugs to treat rare diseases, collapsed in October and lost 40% of their value, based on data from S&P Capital IQ, after the company ...
Aegerion Pharma Buys Drug From AstraZeneca for $325M  Mergers & Acquisitions - The Middle Market
Aegerion Pharmaceuticals (AEGR) to Acquire Myalept from AstraZeneca (AZN ... (subscription)
Related articles »  
Technical Insights on Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)
[Globe Newswire] Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)(TREND ANALYSIS) a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, announced that ...
Aegerion Pharmaceuticals Inc (NASDAQ:AEGR) near 52-week low, short ...
Aegerion Pharmaceuticals Inc (NASDAQ:AEGR) (TREND ANALYSIS) shares were traded with a volume more than two times higher than the usual volume.
Top 4 Price Losers of Biotech Sector: Clovis Oncology Inc (CLVS), Aegerion ...  Street Register
Time To Ring The Register On These Hot Biotech Plays - Vascular Biogenics ...  Wall Street Observer
Companies With High EPS Growth - Aegerion Pharmaceuticals, Inc. (NASDAQ ...
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was trading -46.77% below its 52-week high and 2.23% above its 52-week low.
Q1 Earnings of $-0.31 Anticipated for Aegerion Pharmaceuticals, Inc. (NASDAQ ...  Markets Daily
Large Outflow of Money Witnessed in Aegerion Pharmaceuticals, Inc.  News Watch International
Alex Denner's Sarissa Capital Management Lp Just Reported Giant Aegerion ...
Sarissa Capital Management Lp has filled a SC 13D/A form regarding Aegerion Pharmaceuticals, Inc 20.20 -0.42 -2.04% .
CFO Moves: Arista Networks, 3D Systems, Aegerion Pharmaceuticals
Arista Networks Inc.ANET -0.10%, Santa Clara, Calif., cloud networking company, named Ita Brennan chief financial officer, effective on or before May 18, according to a regulatory filing.
Aegerion Pharmaceuticals Inc. (AEGR) is Trading Lower on Unusual Volume for ...
Aegerion Pharmaceuticals Inc. (AEGR) experienced unusually high volume on May. 15, as the stock lost 5.61% to a closing price of $19.28.
Aegerion Pharmaceuticals, Inc. Soars After Sarissa Capital Discloses Stake
The shares of Aegerion Pharmaceuticals surged after Sarissa Capital Management disclosed its stake in the company. The stock was trading at $25.70 per share, up by more than 8% to $25.87 per share at the time of this writing around 2:33 in the ...
Activist Discloses 5.7% Stake In Aegerion Pharmaceuticals  Benzinga
Form SC 13D Aegerion Pharmaceuticals Filed by: Sarissa Capital Management LP
Stock in Focus : Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)
Aegerion Pharmaceuticals Inc (NASDAQ:AEGR) (TREND ANALYSIS) is expected to report earnings per share of $-1.07 for the current fiscal year, as per consensus of analysts.
Perilous Reversal Stock: Aegerion Pharmaceuticals (AEGR)
Aegerion Pharmaceuticals, Inc. Prices $300 Million Convertible Senior Notes ...
Aegerion Pharmaceuticals, Inc. AEGR, +0.28% today announced the pricing of its offering of $300 million aggregate principal amount of 2.00% convertible senior notes due 2019 to persons that they reasonably believe to be qualified institutional buyers ...
Related articles »